Concomitant Organ Lesions: Diabetic Retinopathy in Early and Advanced Nephropathy

  • Robert C. Ramsay
Part of the Topics in Renal Medicine book series (TIRM, volume 6)


Essentially all patients with clinically significant diabetic nephropathy will also manifest some degree of retinopathy [1]. Both nephropathy and retinopathy are duration-related microvascular complications of chronic hyperglycemia. Major risk factors include duration of diabetes (insulin-dependent or noninsulin-dependent), level of plasma glucose, and systemic hypertension. Other factors, including insulin therapy, ketosis, level of serum lipids, and younger age of onset may also play a role [2]. Genetic susceptibility, as determined by HLA phenotype studies, is important for both retinopathy and nephropathy. Finally, for ocular complications, local factors, such as the presence or absence of myopia, influence the type of retinopathy that ultimately develops [3].


Diabetic Retinopathy Macular Edema Diabetic Macular Edema Proliferative Diabetic Retinopathy Vitreous Hemorrhage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ramsay RC, Knobloch WH, Barbosa JJ, Sutherland DE, Kjellstrand CM, Najarian JS, Goetz FC: The visual status of diabetic patients after renal transplantation. Am J Ophthalmol 87: 305–310, 1979.PubMedGoogle Scholar
  2. 2.
    West KM, Erdreich LJ, Stober JA: A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29: 501–508, 1980.PubMedCrossRefGoogle Scholar
  3. 3.
    Baker RS, Rand LI, Krolewski AS, Maki T, Warram JH, Aiello LM: Influence of HLA-DR phenotype and myopia on the risk of nonproliferative and proliferative diabetic retinopathy. Am J Ophthalmol 102: 693–700, 1986.PubMedGoogle Scholar
  4. 4.
    Diabetic Retinopathy Study Research Group: Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 18: 1–14, 1976.Google Scholar
  5. 5.
    Friedman EA: Overview of diabetic nephropathy. In: Keen H Legrain M (eds) Prevention and treatment of diabetic nephropathy. Boston: MTP Press, 1983, pp 3–19.Google Scholar
  6. 6.
    Friedman EA, L’Esperance FA: Diabetic renal—retinal syndrome: the prognosis improves. Arch Intern Med 140: 1149–1150, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 103: 1796–1806, 1985.CrossRefGoogle Scholar
  8. 8.
    Ramsay RC, Knoboloch WH, Cantrill HL: Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology 93: 283–289, 1986.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Robert C. Ramsay

There are no affiliations available

Personalised recommendations